Preliminary results of a phase I/II study of weekly or twice weekly bortezomib in combination with rituximab, in patients with follicular lymphoma, mantle cell lymphoma and Waldenstrom's macroglobulinaemia

A. Agathocleous; S. Rule; P. Johnson; J. A. Radford; N. Lafon; H. Hunter; J. P. Kerr; S. M. Neeson; J. Matthews; S. Strauss; S. Montoto; A. Z. S. Rohatiner; T. A. Lister

Preliminary results of a phase I/II study of weekly or twice weekly bortezomib in combination with rituximab, in patients with follicular lymphoma, mantle cell lymphoma and Waldenstrom's macroglobulinaemia

A. Agathocleous, S. Rule, P. Johnson, J. A. Radford, N. Lafon, H. Hunter, J. P. Kerr, S. M. Neeson, J. Matthews, S. Strauss, S. Montoto, A. Z. S. Rohatiner, T. A. Lister

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	754A
Number of pages	1
Journal	Blood
Volume	110
Issue number	11
Publication status	Published - 16 Nov 2007
Event	49th Annual Meeting of the American-Society-of-Hematology - Atlanta, Georgia, United States Duration: 8 Dec 2007 → 11 Dec 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Agathocleous, A., Rule, S., Johnson, P., Radford, J. A., Lafon, N., Hunter, H., Kerr, J. P., Neeson, S. M., Matthews, J., Strauss, S., Montoto, S., Rohatiner, A. Z. S., & Lister, T. A. (2007). Preliminary results of a phase I/II study of weekly or twice weekly bortezomib in combination with rituximab, in patients with follicular lymphoma, mantle cell lymphoma and Waldenstrom's macroglobulinaemia. Blood, 110(11), 754A.

@article{5fc050cdbf364c62aff031a58a735d84,

title = "Preliminary results of a phase I/II study of weekly or twice weekly bortezomib in combination with rituximab, in patients with follicular lymphoma, mantle cell lymphoma and Waldenstrom's macroglobulinaemia",

author = "A. Agathocleous and S. Rule and P. Johnson and Radford, {J. A.} and N. Lafon and H. Hunter and Kerr, {J. P.} and Neeson, {S. M.} and J. Matthews and S. Strauss and S. Montoto and Rohatiner, {A. Z. S.} and Lister, {T. A.}",

year = "2007",

month = nov,

day = "16",

language = "English",

volume = "110",

pages = "754A",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier BV",

number = "11",

note = "49th Annual Meeting of the American-Society-of-Hematology ; Conference date: 08-12-2007 Through 11-12-2007",

}

Agathocleous, A, Rule, S, Johnson, P, Radford, JA, Lafon, N, Hunter, H, Kerr, JP, Neeson, SM, Matthews, J, Strauss, S, Montoto, S, Rohatiner, AZS & Lister, TA 2007, 'Preliminary results of a phase I/II study of weekly or twice weekly bortezomib in combination with rituximab, in patients with follicular lymphoma, mantle cell lymphoma and Waldenstrom's macroglobulinaemia', Blood, vol. 110, no. 11, pp. 754A.

Preliminary results of a phase I/II study of weekly or twice weekly bortezomib in combination with rituximab, in patients with follicular lymphoma, mantle cell lymphoma and Waldenstrom's macroglobulinaemia. / Agathocleous, A.; Rule, S.; Johnson, P. et al.
In: Blood, Vol. 110, No. 11, 16.11.2007, p. 754A.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Preliminary results of a phase I/II study of weekly or twice weekly bortezomib in combination with rituximab, in patients with follicular lymphoma, mantle cell lymphoma and Waldenstrom's macroglobulinaemia

AU - Agathocleous, A.

AU - Rule, S.

AU - Johnson, P.

AU - Radford, J. A.

AU - Lafon, N.

AU - Hunter, H.

AU - Kerr, J. P.

AU - Neeson, S. M.

AU - Matthews, J.

AU - Strauss, S.

AU - Montoto, S.

AU - Rohatiner, A. Z. S.

AU - Lister, T. A.

PY - 2007/11/16

Y1 - 2007/11/16

UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000251100803341&KeyUID=WOS:000251100803341

M3 - Meeting Abstract

SN - 0006-4971

VL - 110

SP - 754A

JO - Blood

JF - Blood

IS - 11

T2 - 49th Annual Meeting of the American-Society-of-Hematology

Y2 - 8 December 2007 through 11 December 2007

ER -

Preliminary results of a phase I/II study of weekly or twice weekly bortezomib in combination with rituximab, in patients with follicular lymphoma, mantle cell lymphoma and Waldenstrom's macroglobulinaemia

UN SDGs

Other files and links

Cite this